Session VII: Practical Considerations of ICIs for NSCLC

Moderator(s)

• 

  Edward Garon, MD, MS

  University of California, Los Angeles

Presenter(s)

• 

  Mark Awad, MD, PhD (he/him/his)

  Dana-Farber Cancer Institute, Harvard Medical School
• 

  Lyudmila Bazhenova, MD

  University of California, San Diego
• 

  Helen Ross, MD

  Banner MD Anderson Cancer Center

Presentations:

• 11:10 AM – 11:20 AM

  Welcome and Introduction; Pre-Session Audience Survey
  

  Chair: Edward B. Garon, MD, MS – University of California, Los Angeles
• 11:20 AM – 11:35 AM

  Handling Resistance to CPIs: What’s Sound? What’s Bogus?
  

  Speaker: Mark Awad, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
• 11:35 AM – 11:55 AM

  When are CPIs Inappropriate? Can They be Made Relevant or Safe in “Untested” Populations?
  

  Speaker: Helen J. Ross, MD – Banner MD Anderson Cancer Center
• 11:55 AM – 12:10 PM

  CPIs: Recognizing, Mitigating, and Managing Toxicity
  

  Speaker: Lyudmila Bazhenova, MD – University of California, San Diego
• 12:10 PM – 12:30 PM

  Q&A; Post-Session Audience Survey
  

  Moderator: Edward B. Garon, MD, MS – University of California, Los Angeles

  Panelist: Mark Awad, MD, PhD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School

  Panelist: Lyudmila Bazhenova, MD – University of California, San Diego

  Panelist: Helen J. Ross, MD – Banner MD Anderson Cancer Center